Mikko Myllymäki, MD, PhD, is a Principal Investigator at the Faculty of Medicine and an affiliated Principal Investigator in the Translational Immunology Research Program (TRIMM), Research Programs Unit, University of Helsinki. He currently works as an Academy of Finland Clinical Research fellow. He is also specialising in clinical hematology at HUS Helsinki University Hospital/University of Helsinki. After graduating from University of Oulu, Finland, in 2016, he did a postdoctoral fellowship at the Dana-Farber Cancer Institute and Harvard Medical School, where he studied how telomere length and germline predisposition affect stem cell transplantation outcomes in myelodysplastic syndrome (MDS). Dr. Myllymäki is the Chairman of the Finnish MDS group and a board member of the Nordic MDS group.
Miro Nylén, B.Med, is an MD/PhD student at the University Helsinki and an undergraduate bioinformatics student at Aalto University. His research is focused on investigating the clinical impact of clonal hematopoiesis on inherited and acquired disease conditions.
Emil Hiitola, PhD student. After carrying out his Master's thesis work in the lab (graduated with honors from Aalto University in 2024), Emil has continued his work focusing on the role of clonal hematopoiesis in inflammatory diseases. iCANDOC PhD program participant.
Konstantin Matjusinski, B.Sc., after finishing his Master's thesis project in the lab, Konsta has continued as a PhD student in the iCANDOC PhD student program. Before joining the team, he studied the role of transcription factor Prox1 in radiation resistance and investigated the role of beta integrins and sharpin signalling pathways in maintaining vascular homeostasis.
Juuso Vedenjuoksu is an MD/PhD student at the University Helsinki. His research is focused on finding predictors of myeloid malignancies in large population-level cohorts.
Megan Qin Deng, B.A. Megan did her BA degree at Boston University, USA. Currently working in the lab as a Master's thesis student in the Translational Medicine (University of Helsinki), while also starting her MD studies at University of Tartu, Estonia.
M.Sc. student from University of Oulu. Studying how chromosomal alterations regulate immune cell function.
M.Sc. student from Aalto University. Emilia aims to understand the impact of clonal hematopoiesis on treatment outcomes in solid cancer patients.
Anne Ruosteoja, M.Sc. Graduated from the Translational Medicine Master's program in 2025. Anne developed cell-based assays to understand monocyte/macrophage function in inflammatory diseases.
Rafeul Hasan, M.Sc. Did his Master's thesis project at University of Helsinki (2024) focused on evaluating whether germline factors predisposing to clonal hematopoiesis are associated with inflammatory diseases. Currently a Project Researcher at University of Tampere.
Daehong Kim, Ph.D. Originally from Seoul, Korea. During his PhD studies (graduated in 2022) in the lab, Daehong explored the functional consequences of somatic mutations in hematologic malignancies and related autoimmune diseases. Currently a Postdoctoral Scientist at the Institute of Experimental Immunology, University of Zurich.
Milla Alakuijala, M.Sc. finalised her Master's degree at Aalto University (2022) when she worked on detecting clonal hematopoiesis using novel variant calling methods while combining her interests in medicine, bioinformatics, and computer science. Currently an MD student at the University of Helsinki.
Juuso Korhonen, B.Sc. Performed genetic analyses related to the FINRISK study while working in the lab as a Master's student in Computer Science at Aalto University.